Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
Did you mean weerasena i[au] (1 results)?
Characterizing the Blood-Stage Antimalarial Activity of Tafenoquine in Healthy Volunteers Experimentally Infected With Plasmodium falciparum.
Barber BE, Abd-Rahman AN, Webster R, Potter AJ, Llewellyn S, Marquart L, Sahai N, Leelasena I, Birrell GW, Edstein MD, Shanks GD, Wesche D, Moehrle JJ, McCarthy JS. Barber BE, et al. Among authors: leelasena i. Clin Infect Dis. 2023 Jun 8;76(11):1919-1927. doi: 10.1093/cid/ciad075. Clin Infect Dis. 2023. PMID: 36795050 Free PMC article.
Safety, Tolerability, and Pharmacokinetics of IMU-935, a Novel Inverse Agonist of Retinoic Acid Receptor-Related Orphan Nuclear Receptor γt: Results From a Double-Blind, Placebo-Controlled, First-in-Human Phase 1 Study.
Polasek TM, Leelasena I, Betscheider I, Marolt M, Kohlhof H, Vitt D, Fliegert F, Muehler AR. Polasek TM, et al. Among authors: leelasena i. Clin Pharmacol Drug Dev. 2023 May;12(5):525-534. doi: 10.1002/cpdd.1243. Epub 2023 Mar 20. Clin Pharmacol Drug Dev. 2023. PMID: 36938862 Clinical Trial.
Safety, Tolerability, and Immunogenicity of Measles and Rubella Vaccine Delivered with a High-Density Microarray Patch: Results from a Randomized, Partially Double-Blinded, Placebo-Controlled Phase I Clinical Trial.
Baker B, Bermingham IM, Leelasena I, Hickling J, Young PR, Muller DA, Forster AH. Baker B, et al. Among authors: leelasena i. Vaccines (Basel). 2023 Nov 17;11(11):1725. doi: 10.3390/vaccines11111725. Vaccines (Basel). 2023. PMID: 38006057 Free PMC article.